Table 3.
Symptom/behavioral change | Placebo (%) | Low rapa (%) | High rapa (%) |
---|---|---|---|
Increased water consumption | 3 (38) | 1 (20) | 4 (40) |
Fatigue/lethargy | 1 (13) | 1 (20) | 3 (30) |
Vomiting | 2 (25) | 2 (40) | 2 (20) |
Diarrhea | 3 (38) | 1 (20) | 4 (40) |
Cough | 2 (25) | 1 (20) | 3 (30) |
Skin irritation/rash | 2 (25) | 2 (40) | 2 (20) |
Lipoma | 1 (13) | 0 (0) | 0 (0) |
Limping/slipping | 2 (25) | 2 (40) | 0 (0) |
Constipation | 1 (13) | 0 (0) | 0 (0) |
Eye irritation | 1 (13) | 0 (0) | 1 (10) |
Increased appetite | 1 (13) | 2 (40) | 0 (0) |
Decreased appetite | 1 (13) | 0 (0) | 0 (0) |
Weight loss | 1 (13) | 0 (0) | 0 (0) |
Increased energy | 2 (25) | 2 (40) | 7 (70) |
More affectionate | 0 (0) | 2 (40) | 2 (20) |
Increased alertness | 0 (0) | 0 (0) | 1 (10) |
Symptoms and changes in behavior reported by owners during the 10 weeks that their dog participated in the study. The number of different dogs within each treatment for which a particular symptom or change in behavior was reported at least once during the study is shown with the percentage of dogs shown in parentheses